Fundz

Octagon Therapeutics reported raising $11 Million in an initial SEC Form D filing, from an offering of $12.4 Million

PRIVATEFeb 12, 2024

Amount Raised

$11 Million

$11 Million sold, per SEC Form D (first sale Jan 29, 2024)

Round Type

Venture

ProvidenceHealthcare

Who to call at Octagon Therapeutics, and when

A new round usually means Octagon Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Octagon Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Octagon Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Octagon Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Octagon Therapeutics

Location

225 DYER ST.

Providence, Rhode Island, United States

About

Octagon is developing new medicines for autoimmune and inflammatory disease. The company is pioneering a selective immunomodulation approach based on glyco-immune checkpoint receptors that allows for precise targeting of disease-driving immune processes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Octagon Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts9 people are listed at Octagon Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Octagon Therapeutics's next move

See what Strategic adds

Octagon Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.